Published in:
01-02-2014 | Letter to the Editor
Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer
Authors:
R. Sawaya, W. Radwan, S. Hammoud
Published in:
Medical Oncology
|
Issue 2/2014
Login to get access
Excerpt
Posterior reversible encephalopathy syndrome (PRES) is now a well-described entity in neurology, diagnosed by the clinical picture of altered mental status, headache, visual disturbances, hypertension and seizures, associated with the classical MRI findings of cortical and subcortical abnormalities in multiple brain areas, predominantly in the posterior lobes. …